Envoy Medical shareholders approve 7.2M share expansion for employee compensation plans

Filed May 18, 2026 · Period ending May 12, 2026 · ~1 min read

Key Changes

• medium

  Stockholders authorized 6 million additional shares for the 2023 Equity Incentive Plan, expanding the pool available for employee stock grants and options. This represents potential dilution but is standard for growth-stage companies attracting talent.

  Item 5.07 verify on EDGAR →
• medium

  An additional 1.2 million shares were approved for the Employee Stock Purchase Plan, bringing total new shares authorized across both plans to 7.2 million. Both amendments became effective immediately upon May 12, 2026 stockholder approval.

  Item 5.07 verify on EDGAR →
• medium

  Shareholders ratified warrants issued in February 2026 to comply with Nasdaq Listing Rule 5635(d). The warrants were already issued; this vote provides required regulatory approval after the fact.

  Item 5.07 verify on EDGAR →